Year 2Pharmacotherapeutics-I7 min readOfficial Syllabus
Drug induced pulmonary diseases
Curriculum Unit: 2. Respiratory system:
Overview & Academic Context
This study module covers "Drug induced pulmonary diseases", an integral component of the Year 2 Doctor of Pharmacy (Pharm.D) curriculum under Pharmacotherapeutics-I (Respiratory system). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.
Core Study Concepts
Drug induced pulmonary diseasesRespiratory system
Learning Objectives
Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:
- Understand the foundational etiology, classification, and clinical significance of Drug induced pulmonary diseases.
- Analyze the underlying pathophysiology and disease manifestations relevant to Respiratory system.
- Evaluate evidence-based pharmacotherapeutic management, therapeutic drug choices, and dosage individualization.
- Identify critical patient monitoring parameters, adverse drug reactions (ADRs), and drug-drug interactions.
Full Study Notes & Interactive Hub
Unlock Complete Interactive Notes for Drug induced pulmonary diseases
Access clinical pathophysiology flowcharts, high-yield treatment algorithms, dose adjustment tables, AMBOSS-style search, interactive self-assessment quizzes, and board-exam mnemonics.
Protected educational content reserved for authorized Pharm.D students and faculty.
Curriculum References & Recommended Texts
Standard literature and institutional sources for Pharmacotherapeutics-I:
- [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
- [2]Pharmacotherapy: A Pathophysiologic Approach (Joseph T. DiPiro et al.)
- [3]Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs
- [4]Standard National and International Clinical Practice Guidelines (WHO, ACC/AHA, IDSA)